-
Boston Scientific Estimates Updated For 2010 And Beyond
Thursday, July 22, 2010 - 8:52am | 96Read More...Boston Scientific Corporation (NYSE: BSX) has reported solid 2Q results, with sales at $1.928B, coming in $17M above Street consensus. EPS showed at $0.12, one penny below J.P. Morgan's estimate, thanks to strong gross margin and lower operating expenses. JPM projects EPS of $0.60 for the full...
-
Argus Downgrades Boston Scientific (BSX)
Monday, March 1, 2010 - 4:29pm | 80Read More...Argus Research has downgraded shares of Boston Scientific (NYSE: BSX) from Buy to Hold this afternoon. Despite the lowered investment rating, shares of BSX are up modestly, trading around $7.77. Boston Scientific, subsidiary Guidant, was recently charged with failing to report safety problems with...
